Summary: Lilly's Phase II results for Alzheimer's drug donanemab have raised doubts among experts due to mixed results and questions on the clinical significance of the primary endpoint. Stock dropped 9% following the publication of the data on 13 March 2021. These concerns are amplified by uncertainties over the drug's long-term effects, ARIA adverse events, and the Phase III trial's ability to address lingering questions.
Full articleSummary: Citigroup Inc. is ramping up efforts to provide tailored products to medium-size companies in Japan, creating a team in Tokyo under the brand of Citi Commercial Bank.
Full articleSummary: Recent lawsuits highlight allegations of age discrimination and discrimination based on sexual orientation and gender identity by certain employers, with specific cases involving RTX Corp. (formerly known as Raytheon Technologies Corp.), Harmony Hospitality LLC, and LAS Hardwoods.
Full articleSummary: Oracle partners with Tamil Nadu Skill Development Corporation for the Naan Mudhalvan program to provide IT skills training in cloud computing, data science, AI, ML, and blockchain to over 200,000 students.
Full articleSummary: Wells Fargo fired employees for using 'mouse jiggler' software to fake their keyboard activity and deceive the company during work hours, sparking privacy concerns and debates on monitoring employees' online activities.
Full articleSummary: Devyser Diagnostics AB expands collaboration and distribution agreement with Thermo Fisher Scientific, giving Thermo Fisher exclusive rights to commercialize Devyser's post-transplant portfolio of NGS products globally.
Full articleSummary: Devyser Diagnostics AB expanded its collaboration and distribution agreement with Thermo Fisher Scientific for the commercialization of Devyser’s post-transplant portfolio of NGS products globally. Thermo Fisher now has exclusive rights globally under combined brands. The agreement includes products for graft rejection detection in stem cell transplant patients and donor-derived cell-free DNA in kidney transplant patients.
Full articleSummary: Oracle's stock price jumped 13% post better-than-expected Q4 FY2024 results and partnership announcements. ORCL stock has outperformed S&P 500 over the last 3 years and is currently trading at fair value. The company expects further growth in FY2025 with estimated revenues of $57.7 billion.
Full articleSummary: Google Gemini predicts a significant price increase for XRP by July 1st, 2024, bolstered by positive developments including potential ETF and institutional interest for XRP in international payments. Ongoing legal battle between Ripple and SEC continues to influence XRP's price.
Full articleSummary: Dollar Index rebounded slightly due to hawkish comments from Federal Reserve officials. Crude oil prices retraced from two-week highs amidst market uncertainties. Japanese Yen continued to sell off.
Full articleSummary: Boeing is in talks to buy Spirit AeroSystems, a key supplier that makes the fuselage for Boeing in Wichita, Kansas, as a part of rebuilding its reputation for quality. Both companies are working on improving manufacturing quality and trust of regulators and the public.
Full articleSummary: Intuit Inc. (NASDAQ:INTU) experienced a significant rise in short interest in May. Analysts have set new price targets with majority rating the stock as a buy. Insiders have been actively selling company stock. Institutional investors have also been buying and selling shares of the stock.
Full articleSummary: The article discusses how the Federal Reserve's decisions on interest rates affect the prices of commodities like gold and silver. It explains that higher rates make non-yielding assets less attractive, leading to lower prices for gold and silver, while lower rates increase their attractiveness, often raising prices. The piece also highlights the impact of interest rates on inflation, the strength of the dollar, and the importance of staying informed, diversifying investments, hedging, and using technical analysis in commodity trading.
Full articleSummary: Nasdaq marked fifth record closing highs driven by tech frenzy, S&P 500 and Dow Jones closed marginally lower due to soft Consumer sentiment reading. Consumer sentiment fell to 65.6 with increased inflation expectation, impacting US economy and Federal Reserve indicating a wait for cooler inflation data. Key events this week include Retail Sales and S&P Global Flash PMIs. S&P 500 eyes resistance at 5500.
Full articleSummary: Lowe's Companies, Inc. has shown significant growth over the past decade, with a $1000 investment made in December 2012 now worth $5,952.90, reflecting a 495.29% gain. Analysts are optimistic about Lowe's future outlook, expecting more upside due to its strong performance in the home improvement market.
Full articleSummary: Union Pacific donated and painted the 4141 Locomotive to the George and Barbara Bush Foundation. A new pavilion was opened to the public to celebrate the locomotive and Marine One helicopter, both significant pieces of history. The locomotive, functioning since 2005, weighs over 400,000 pounds and has over 4,000 horsepower.
Full articleSummary: Key economic data such as US retail sales, factory output, and home builder confidence index, along with earnings reports from Accenture and Kroger, are expected to guide the stock markets in the upcoming week.
Full articleSummary: Napa Wealth Management bought a new position in Mastercard during the 4th quarter, with other hedge funds also increasing their stakes in the company. Insiders were also active, with major shareholder Foundation Mastercard selling a significant number of shares. Mastercard's stock performance showed a market cap of $413.33 billion and a recent opening price of $444.63 on Friday. Analysts have set various price targets for the stock.
Full articleSummary: The article discusses the expected growth in the self-storage and apartment sectors in the US real estate market, focusing on Equity Residential (NYSE:EQR) as a key player with positive outlook and recent positive developments.
Full articleSummary: FDA has a busy week ahead with six target action dates. Merck awaiting verdict on pneumococcal shot, Argenx seeks approval for Vyvgart Hytrulo in CIDP, BMS targets Krazati expansion into CRC among other drug applications.
Full articleSummary: Emerson released its 2023 Sustainability Report showcasing progress towards net zero operations and investment in employees and communities.
Full articleSummary: Elavon and BMO have partnered to offer innovative payment solutions to BMO's clients in the United States, providing services like core acquiring and processing, omnichannel acceptance, dynamic and multi-currency conversion, and fraud management.
Full articleSummary: Pfizer Vietnam has signed a memorandum of understanding with two hospitals in Ha Noi to carry out a programme for antimicrobial resistance awareness and stewardship, aiming to advance national strategy goals for 2023-30. The programme includes collaboration in organising scientific conferences, training programmes, and raising awareness and surveillance on antimicrobial resistance.
Full articleSummary: Altria Group (NYSE:MO) continues to offer value for income-focused investors despite challenges in the tobacco industry, with a strategic shift towards e-vapor products and strong dividends. The company's recent moves like selling a part of its stake in Anheuser-Busch and focusing on core business indicate a positive direction.
Full articleSummary: Google Australia has announced the launch of the AI First Accelerator, a program designed to empower Australian startups with cutting-edge AI capabilities. The accelerator is open to Seed and Series A stage startups developing AI and ML-driven platforms and products.
Full articleSummary: Coca-Cola Bottling Company United, Inc. (UNITED) hosted a ceremony to commemorate the groundbreaking of a new facility in Birmingham's Kingston community, with a $330 million investment creating up to 50 new jobs and retaining more than 750 jobs.
Full articleSummary: Deere (DE) closed below the S&P 500, with recent estimate revisions impacting its Zacks Rank and valuation metrics.
Full article